ALIVUS Q1 FY27 results at a glance
ALIVUS LIFE SCIENCES LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹640 cr |
|---|
| Revenue YoY | +6.4% |
|---|
| Operating profit | ₹191 cr |
|---|
| Operating margin | 29.8% |
|---|
| Net profit | ₹160 cr |
|---|
| Net profit YoY | +31.7% |
|---|
| Net profit QoQ | -1.6% |
|---|
| Net margin | 25.0% |
|---|
| Basic EPS | ₹13.04 |
|---|
| TTM revenue | ₹2,604 cr |
|---|
| TTM net profit | ₹595 cr |
|---|
| TTM net margin | 22.8% |
|---|
ALIVUS Q1 FY27 results: what the numbers say
ALIVUS LIFE SCIENCES LTD (ALIVUS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹640 cr and a net profit of ₹160 cr, translating into earnings per share of ₹13.04.
Compared with the same quarter a year earlier, revenue grew by +6.4% and net profit grew strongly by +31.7%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹191 cr, an operating margin of 29.8% versus 25.8% a year ago — a gain of 4.0 percentage points.
ALIVUS quarter-wise results table
Net profit
₹160 cr
+31.7% YoY
Operating profit
₹191 cr
+23.1% YoY
ALIVUS LIFE SCIENCES LTD (ALIVUS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹640 cr | ₹191 cr | ₹160 cr | 29.8% | 25.0% | ₹13.04 | +31.7% | -1.6% |
| Q4 FY262026-03-31 | ₹689 cr | ₹194 cr | ₹163 cr | 28.2% | 23.6% | ₹13.23 | +14.7% | +8.3% |
| Q3 FY262025-12-31 | ₹673 cr | ₹212 cr | ₹150 cr | 31.4% | 22.3% | ₹12.25 | — | +23.6% |
| Q1 FY262025-06-30 | ₹602 cr | ₹155 cr | ₹122 cr | 25.8% | 20.2% | ₹9.91 | — | -14.3% |
| Q4 FY252025-03-31 | ₹650 cr | ₹182 cr | ₹142 cr | 28.1% | 21.8% | ₹11.57 | — | — |
| TTM (last 4 quarters) | ₹2,604 cr | ₹752 cr | ₹595 cr | 28.9% | 22.8% | ₹48.43 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
ALIVUS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ALIVUS LIFE SCIENCES LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹640 cr | ₹689 cr | ₹673 cr | ₹602 cr | ₹650 cr |
|---|
| Total expenses | ₹449 cr | ₹495 cr | ₹461 cr | ₹447 cr | ₹467 cr |
|---|
| Gross profit | ₹385 cr | ₹418 cr | ₹396 cr | ₹331 cr | ₹367 cr |
|---|
| Operating profit (EBIT) | ₹191 cr | ₹194 cr | ₹212 cr | ₹155 cr | ₹182 cr |
|---|
| Operating margin | 29.8% | 28.2% | 31.4% | 25.8% | 28.1% |
|---|
| Interest cost | ₹1.31 cr | ₹1.31 cr | ₹1.49 cr | ₹1.25 cr | ₹1.26 cr |
|---|
| Profit before tax | ₹212 cr | ₹216 cr | ₹198 cr | ₹163 cr | ₹191 cr |
|---|
| Tax expense | ₹52.15 cr | ₹53.14 cr | ₹48.13 cr | ₹41.45 cr | ₹49.42 cr |
|---|
| Effective tax rate | 24.6% | 24.6% | 24.3% | 25.4% | 25.8% |
|---|
| Net profit (PAT) | ₹160 cr | ₹163 cr | ₹150 cr | ₹122 cr | ₹142 cr |
|---|
| Net profit margin | 25.0% | 23.6% | 22.3% | 20.2% | 21.8% |
|---|
| Basic EPS | ₹13.04 | ₹13.23 | ₹12.25 | ₹9.91 | ₹11.57 |
|---|
| Diluted EPS | ₹13.01 | ₹13.22 | ₹12.22 | ₹9.88 | ₹11.55 |
|---|
ALIVUS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +6.4% | +6.1% | — | — | — |
|---|
| Revenue QoQ | -7.1% | +2.4% | +11.8% | -7.3% | — |
|---|
| Operating profit YoY | +23.1% | +6.5% | — | — | — |
|---|
| Operating profit QoQ | -1.6% | -8.2% | +36.3% | -14.9% | — |
|---|
| Net profit YoY | +31.7% | +14.7% | — | — | — |
|---|
| Net profit QoQ | -1.6% | +8.3% | +23.6% | -14.3% | — |
|---|
| EPS YoY | +31.6% | +14.3% | — | — | — |
|---|
| EPS QoQ | -1.4% | +8.0% | +23.6% | -14.3% | — |
|---|
ALIVUS annual results history
Full-year performance for ALIVUS LIFE SCIENCES LTD, useful for reading each quarter in context.
ALIVUS LIFE SCIENCES LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹2,504 cr | ₹2,340 cr | ₹2,185 cr | ₹2,048 cr |
|---|
| Total expenses | ₹1,782 cr | ₹1,716 cr | ₹1,563 cr | ₹1,447 cr |
|---|
| Gross profit | ₹1,388 cr | ₹1,221 cr | ₹1,164 cr | ₹1,016 cr |
|---|
| Operating profit (EBIT) | ₹722 cr | ₹624 cr | ₹622 cr | ₹601 cr |
|---|
| Operating margin | 28.9% | 26.7% | 28.5% | 29.3% |
|---|
| Interest cost | ₹5.37 cr | ₹2.41 cr | ₹1.55 cr | ₹0.55 cr |
|---|
| Profit before tax | ₹751 cr | ₹654 cr | ₹631 cr | ₹629 cr |
|---|
| Tax expense | ₹187 cr | ₹169 cr | ₹160 cr | ₹162 cr |
|---|
| Effective tax rate | 24.9% | 25.8% | 25.4% | 25.7% |
|---|
| Net profit (PAT) | ₹564 cr | ₹486 cr | ₹471 cr | ₹467 cr |
|---|
| Net profit margin | 22.5% | 20.8% | 21.6% | 22.8% |
|---|
| Basic EPS | ₹45.99 | ₹39.63 | ₹38.43 | ₹38.11 |
|---|
| Diluted EPS | ₹45.90 | ₹39.52 | ₹38.38 | ₹38.11 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹640 cr against ₹602 cr in Q1 FY26, and ₹689 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -7.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹449 cr, or 70.2% of revenue, with operating profit grew +23.1% year on year.
Margins, tax and profitability
Net profit of ₹160 cr works out to a net margin of 25.0% compared with 20.2% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, ALIVUS LIFE SCIENCES LTD reported profit before tax of ₹212 cr, a tax charge of ₹52.15 cr (effective rate 24.6%), interest cost of ₹1.31 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹163 cr in Q4 FY26 to ₹160 cr in Q1 FY27, a change of -1.6%.
Trailing twelve months and annual context
Across the trailing four quarters ALIVUS LIFE SCIENCES LTD has generated revenue of ₹2,604 cr and net profit of ₹595 cr, a trailing net margin of 22.8%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹2,504 cr with net profit of ₹564 cr and EPS of ₹45.99, versus the prior year where revenue grew +7.0% and profit grew +16.2%.
What to watch in the next ALIVUS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ALIVUS LIFE SCIENCES LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
ALIVUS results coverage
No results report published for ALIVUS yet — our desk covers each quarter within minutes of the filing.
ALIVUS quarterly results FAQs
What were ALIVUS LIFE SCIENCES LTD (ALIVUS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ALIVUS LIFE SCIENCES LTD reported revenue of ₹640 cr and net profit of ₹160 cr, a change of +31.7% year on year on +6.4% revenue growth. EPS stood at ₹13.04.
What is ALIVUS profit margin in Q1 FY27?
ALIVUS LIFE SCIENCES LTD posted a net profit margin of 25.0% and an operating margin of 29.8% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹2,604 cr and net profit ₹595 cr.
Did ALIVUS results beat the previous quarter?
ALIVUS LIFE SCIENCES LTD net profit changed -1.6% quarter on quarter, from ₹163 cr in Q4 FY26 to ₹160 cr in Q1 FY27.
When are ALIVUS LIFE SCIENCES LTD (ALIVUS) quarterly results?
ALIVUS LIFE SCIENCES LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see ALIVUS latest quarterly results?
Results coverage for ALIVUS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the ALIVUS stock page.
What is ALIVUS LIFE SCIENCES LTD annual revenue and profit?
For FY26, ALIVUS LIFE SCIENCES LTD reported full-year revenue of ₹2,504 cr and net profit of ₹564 cr, with EPS of ₹45.99.
How many quarterly results has ALIVUS declared recently?
Past results dates for ALIVUS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
